PUBLISHER: KBV Research | PRODUCT CODE: 1101877
PUBLISHER: KBV Research | PRODUCT CODE: 1101877
Asia Pacific Intravenous Immunoglobulin Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, and Others), By Application, By Country and Growth Forecast, 2022 - 2028
The Asia Pacific Intravenous Immunoglobulin Market would witness market growth of 7.8% CAGR during the forecast period (2022-2028).
The term immunoglobulin refers to the breakdown of antibody-containing blood plasma. IVIg (intravenous immunoglobulin) is a blood product that is given intravenously. It's made up of polyvalent IgG antibodies collected from the plasma of thousands of blood donors. Patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia, and other kinds of hypogammaglobulinemia who are unable to make significant amounts of antibodies, get benefit from IVIg to maintain the right amount of antibodies in the body.
The comprehensive market for IVIg is divided into two categories i.e. plasma protein and therapeutic area. Polyvalent IVIg, albumin, Factor VIII, hyperimmune (IM&IV), and Factor IX are all part of the plasma protein. Immune deficiencies, autoimmune disorders, and acute infections are also included in the therapeutic area segment. The immune deficiency includes important disorders with low antibody levels, such as hypogammaglobulinemia (primary immune deficiencies), X-linked agammaglobulinemia (secondary immune deficiencies), and acquired weakened immunity syndromes (secondary immunological deficiencies). Immune thrombocytopenia and inflammatory disorders are two types of autoimmune illnesses.
The regional government and medical association are making efforts to strengthen the healthcare infrastructure in order to suit newly brought medical technology like intravenous immunoglobulin. The Ministry of Education, the Central Committee of the Communist Youth League, the State Ethnic Affairs Commission, among others, conducted different kinds of publicity and education activities for the AIDS response, depending on the respective work advantages and concentrating on such groups as teenagers, migrant workers, and women. In terms of prevention and treatment, the percentage of female sex workers living with HIV has remained relatively low in recent years.
The China market dominated the Asia Pacific Intravenous Immunoglobulin Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,150.2 million by 2028. The Japan market is poised to grow at CAGR of 7.1% during (2022 - 2028). Additionally, The India market would display a CAGR of 8.5% during (2022 - 2028).
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Specialty Pharmacy, and Others. Based on Application, the market is segmented into Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy, Hypogammaglobulinemia, Chronic Lymphocytic Leukemia & Myasthenia Gravis, Congenital AIDS & Multifocal Motor Neuropathy, Kawasaki Disease, Guillain-Barre Syndrome, Immune thrombocytopenia (ITP), and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Grifols, S.A., Takeda Pharmaceutical Company Limited, Baxter International, Inc., Biotest AG (Tiancheng International Investment Limited), LFB S.A., CSL Limited (CSL Behring), Octapharma AG, Kedrion S.p.A, and Bayer AG.
Scope of the Study
Market Segments covered in the Report:
By Distribution Channel
- Hospital Pharmacy
- Specialty Pharmacy
- Others
By Application
- Immunodeficiency Diseases
- Chronic Inflammatory Demyelinating Polyneuropathy
- Hypogammaglobulinemia
- Chronic Lymphocytic Leukemia & Myasthenia Gravis
- Congenital AIDS & Multifocal Motor Neuropathy
- Kawasaki Disease
- Guillain-Barre Syndrome
- Immune thrombocytopenia (ITP)
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- Grifols, S.A.
- Takeda Pharmaceutical Company Limited
- Baxter International, Inc.
- Biotest AG (Tiancheng International Investment Limited)
- LFB S.A.
- CSL Limited (CSL Behring)
- Octapharma AG
- Kedrion S.p.A
- Bayer AG
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Asia Pacific Intravenous Immunoglobulin Market, by Distribution Channel
- 1.4.2 Asia Pacific Intravenous Immunoglobulin Market, by Application
- 1.4.3 Asia Pacific Intravenous Immunoglobulin Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel
- 3.1 Asia Pacific Hospital Pharmacy Market by Country
- 3.2 Asia Pacific Specialty Pharmacy Market by Country
- 3.3 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Intravenous Immunoglobulin Market by Application
- 4.1 Asia Pacific Immunodeficiency Diseases Market by Country
- 4.2 Asia Pacific Chronic Inflammatory Demyelinating Polyneuropathy Market by Country
- 4.3 Asia Pacific Hypogammaglobulinemia Market by Country
- 4.4 Asia Pacific Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country
- 4.5 Asia Pacific Congenital AIDS & Multifocal Motor Neuropathy Market by Country
- 4.6 Asia Pacific Kawasaki Disease Market by Country
- 4.7 Asia Pacific Guillain-Barre Syndrome Market by Country
- 4.8 Asia Pacific Immune thrombocytopenia (ITP) Market by Country
- 4.9 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Intravenous Immunoglobulin Market by Country
- 5.1 China Intravenous Immunoglobulin Market
- 5.1.1 China Intravenous Immunoglobulin Market by Distribution Channel
- 5.1.2 China Intravenous Immunoglobulin Market by Application
- 5.2 Japan Intravenous Immunoglobulin Market
- 5.2.1 Japan Intravenous Immunoglobulin Market by Distribution Channel
- 5.2.2 Japan Intravenous Immunoglobulin Market by Application
- 5.3 India Intravenous Immunoglobulin Market
- 5.3.1 India Intravenous Immunoglobulin Market by Distribution Channel
- 5.3.2 India Intravenous Immunoglobulin Market by Application
- 5.4 South Korea Intravenous Immunoglobulin Market
- 5.4.1 South Korea Intravenous Immunoglobulin Market by Distribution Channel
- 5.4.2 South Korea Intravenous Immunoglobulin Market by Application
- 5.5 Singapore Intravenous Immunoglobulin Market
- 5.5.1 Singapore Intravenous Immunoglobulin Market by Distribution Channel
- 5.5.2 Singapore Intravenous Immunoglobulin Market by Application
- 5.6 Malaysia Intravenous Immunoglobulin Market
- 5.6.1 Malaysia Intravenous Immunoglobulin Market by Distribution Channel
- 5.6.2 Malaysia Intravenous Immunoglobulin Market by Application
- 5.7 Rest of Asia Pacific Intravenous Immunoglobulin Market
- 5.7.1 Rest of Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel
- 5.7.2 Rest of Asia Pacific Intravenous Immunoglobulin Market by Application
Chapter 6. Company Profiles
- 6.1 Grifols, S.A
- 6.1.1 Company Overview
- 6.1.2 Financial Analysis
- 6.1.3 Regional & Segmental Analysis
- 6.1.4 Research & Development Expenses
- 6.1.5 Recent strategies and developments:
- 6.1.5.1 Product Launches and Product Expansions:
- 6.1.5.2 Acquisition and Mergers:
- 6.2 Takeda Pharmaceutical Company Limited
- 6.2.1 Company Overview
- 6.2.2 Financial Analysis
- 6.2.3 Regional Analysis
- 6.2.4 Research & Development Expense
- 6.2.5 Recent strategies and developments:
- 6.2.5.1 Approvals and Trials:
- 6.3 Baxter International, Inc.
- 6.3.1 Company Overview
- 6.3.2 Financial Analysis
- 6.3.3 Regional Analysis
- 6.3.4 Research & Development Expense
- 6.4 Biotest AG (Tiancheng International Investment Limited)
- 6.4.1 Company Overview
- 6.4.2 Financial Analysis
- 6.4.3 Segmental and Regional Analysis
- 6.4.4 Research & Development Expense
- 6.5 LFB S.A.
- 6.5.1 Company Overview
- 6.5.2 Recent strategies and developments:
- 6.5.2.1 Partnerships, Collaborations, and Agreements:
- 6.6 CSL Limited (CSL Behring)
- 6.6.1 Company Overview
- 6.6.2 Financial Analysis
- 6.6.3 Segmental and Regional Analysis
- 6.6.4 Research & Development Expense
- 6.7 Octapharma AG
- 6.7.1 Company Overview
- 6.7.2 Recent strategies and developments:
- 6.7.2.1 Approvals and Trials:
- 6.8 Kedrion S.p.A
- 6.8.1 Company Overview
- 6.8.2 Financial Analysis
- 6.8.3 Segmental and Regional Analysis
- 6.8.4 Research & Development Expenses
- 6.9 Bayer AG
- 6.9.1 Company Overview
- 6.9.2 Financial Analysis
- 6.9.3 Segmental and Regional Analysis
- 6.9.4 Research & Development Expense
LIST OF TABLES
- TABLE 1 Asia Pacific Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
- TABLE 2 Asia Pacific Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
- TABLE 3 Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 4 Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 5 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 6 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 7 Asia Pacific Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
- TABLE 8 Asia Pacific Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
- TABLE 9 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
- TABLE 10 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
- TABLE 11 Asia Pacific Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
- TABLE 12 Asia Pacific Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
- TABLE 13 Asia Pacific Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
- TABLE 14 Asia Pacific Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
- TABLE 15 Asia Pacific Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2018 - 2021, USD Million
- TABLE 16 Asia Pacific Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2022 - 2028, USD Million
- TABLE 17 Asia Pacific Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
- TABLE 18 Asia Pacific Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
- TABLE 19 Asia Pacific Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2018 - 2021, USD Million
- TABLE 20 Asia Pacific Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2022 - 2028, USD Million
- TABLE 21 Asia Pacific Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2018 - 2021, USD Million
- TABLE 22 Asia Pacific Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2022 - 2028, USD Million
- TABLE 23 Asia Pacific Kawasaki Disease Market by Country, 2018 - 2021, USD Million
- TABLE 24 Asia Pacific Kawasaki Disease Market by Country, 2022 - 2028, USD Million
- TABLE 25 Asia Pacific Guillain-Barre Syndrome Market by Country, 2018 - 2021, USD Million
- TABLE 26 Asia Pacific Guillain-Barre Syndrome Market by Country, 2022 - 2028, USD Million
- TABLE 27 Asia Pacific Immune thrombocytopenia (ITP) Market by Country, 2018 - 2021, USD Million
- TABLE 28 Asia Pacific Immune thrombocytopenia (ITP) Market by Country, 2022 - 2028, USD Million
- TABLE 29 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
- TABLE 30 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
- TABLE 31 Asia Pacific Intravenous Immunoglobulin Market by Country, 2018 - 2021, USD Million
- TABLE 32 Asia Pacific Intravenous Immunoglobulin Market by Country, 2022 - 2028, USD Million
- TABLE 33 China Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
- TABLE 34 China Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
- TABLE 35 China Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 36 China Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 37 China Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
- TABLE 38 China Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
- TABLE 39 Japan Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
- TABLE 40 Japan Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
- TABLE 41 Japan Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 42 Japan Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 43 Japan Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
- TABLE 44 Japan Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
- TABLE 45 India Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
- TABLE 46 India Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
- TABLE 47 India Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 48 India Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 49 India Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
- TABLE 50 India Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
- TABLE 51 South Korea Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
- TABLE 52 South Korea Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
- TABLE 53 South Korea Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 54 South Korea Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 55 South Korea Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
- TABLE 56 South Korea Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
- TABLE 57 Singapore Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
- TABLE 58 Singapore Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
- TABLE 59 Singapore Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 60 Singapore Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 61 Singapore Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
- TABLE 62 Singapore Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
- TABLE 63 Malaysia Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
- TABLE 64 Malaysia Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
- TABLE 65 Malaysia Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 66 Malaysia Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 67 Malaysia Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
- TABLE 68 Malaysia Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
- TABLE 69 Rest of Asia Pacific Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
- TABLE 70 Rest of Asia Pacific Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
- TABLE 71 Rest of Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
- TABLE 72 Rest of Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
- TABLE 73 Rest of Asia Pacific Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
- TABLE 74 Rest of Asia Pacific Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
- TABLE 75 Key information - Grifols, S.A.
- TABLE 76 Key Information - Takeda Pharmaceutical Company Limited
- TABLE 77 Key Information - Baxter International, Inc.
- TABLE 78 key information - Biotest AG
- TABLE 79 Key Information - LFB S.A
- TABLE 80 key Information - CSL Limited
- TABLE 81 Key Information - Octapharma AG
- TABLE 82 key Information - Kedrion S.p.A
- TABLE 83 Key Information - Bayer AG
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Recent strategies and developments: Grifols, S.A.
